Contract for the Supply of Stockpiled Medicines

Contract for the Supply of Stockpiled Medicines

Procurement exercise for a contract for the supply of stockpiled medicines to include: lopinavir/ritonavir — tablets or oral solution; hydroxychloroquine – tablets.

United Kingdom-Runcorn: Pharmaceutical products

2020/S 095-228326

Contract notice

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Official name: Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Postal address: 2nd Floor, Rutland House
Town: Runcorn
NUTS code: UK
Postal code: WA7 2ES
Country: United Kingdom
E-mail: Lynne.Nichols@dhsc.gov.uk
Internet address(es):Main address: https://dh.bravosolution.co.uk

I.2)Information about joint procurement

The contract is awarded by a central purchasing body

I.3)Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: https://dh.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://dh.bravosolution.co.uk
Tenders or requests to participate must be submitted to the abovementioned address

I.4)Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

Contract for the Supply of Stockpiled Medicines

Reference number: CM/EMP/20/1622

II.1.2)Main CPV code

33600000

II.1.3)Type of contract

Supplies

II.1.4)Short description:

Procurement exercise for a contract for the supply of stockpiled medicines to include: lopinavir/ritonavir — tablets or oral solution; hydroxychloroquine — tablets; dexamethasone — oral solution or tablets and azithromycin — capsules, tablets or oral solution. Deliveries will be required over an initial period between 15th June and 30 September 2020 with an option to extend for up to an additional 4 months.

The Authority’s preferred presentations and strengths of the medicines and alternative presentations and strengths and presentations which may be acceptable, are specified in the procurement documents.

II.1.5)Estimated total value

Value excluding VAT: 35 000 000.00 GBP

II.1.6)Information about lots

This contract is divided into lots: yes
Tenders may be submitted for all lots
II.2)Description

II.2.1)Title:

Lopinavir/Ritonavir — Tablets or oral Solution

Lot No: 1

II.2.2)Additional CPV code(s)

33600000

II.2.3)Place of performance

NUTS code: UK
Main site or place of performance:

To a location in England to be notified to the successful bidder(s) following contract award.

II.2.4)Description of the procurement:

This procurement exercise may result in one or more contracts for the provision of lopinavir/ritonavir tablets or oral solution.

The volumes required by the Authority are up to 1.4 million tablets in packs of up to 120 tablets

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 15/06/2020
End: 31/01/2021
This contract is subject to renewal: no

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: yes
Description of options:

The contract has the option to be extended for up to an additional 4 months and the option for the authority to order an additional volume of the goods to be procured by up to 50 % subject to the agreement of the supplier.

II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

Lots may be awarded to more than one supplier depending on the volume offered and in accordance with the Authority’s requirements as further specified in the procurement documents.

II.2)Description

II.2.1)Title:

Hydroxychloroquine — tablets

Lot No: 2

II.2.2)Additional CPV code(s)

33600000

II.2.3)Place of performance

NUTS code: UK
Main site or place of performance:

To a location in England to be notified to the successful bidder(s) following contract award.

II.2.4)Description of the procurement:

This procurement exercise may result in one or more contracts for the provision of hydroxychloroquine tablets.

The volumes required by the authority are up to 16 million tablets in packs of up to 100 tablets.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 15/06/2020
End: 31/01/2021
This contract is subject to renewal: no

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: yes
Description of options:

The contract has the option to be extended for up to an additional 4 months and the option for the Authority to order an additional volume of the goods to be procured by up to 50 % subject to the agreement of the supplier.

II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

Lots may be awarded to more than one supplier depending on volume offered and in accordance with the Authority’s requirements as further specified in the procurement documents.

II.2)Description

II.2.1)Title:

Dexamethasone — Oral Solution or Tablets

Lot No: 3

II.2.2)Additional CPV code(s)

33600000

II.2.3)Place of performance

NUTS code: UK
Main site or place of performance:

To a location in England to be notified to the successful bidder(s) following contract.

II.2.4)Description of the procurement:

This procurement exercise may result in one or more contracts for the provision of dexamethasone 2 mg/5 ml oral solution.

The volumes required by the authority are up to 7 000 litres in either 75 ml or 150 ml bottles.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 15/06/2020
End: 31/01/2021
This contract is subject to renewal: no

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: yes
Description of options:

The contract has the option to be extended for up to an additional 4 months and the option for the authority to order an additional volume of the goods to be procured by up to 50 % subject to the agreement of the supplier.

II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

Lots may be awarded to more than one supplier depending on the volume offered and in accordance with the authority’s requirements as further specified in the procurement documents.

II.2)Description

II.2.1)Title:

Azithromycin — Capsules, Tablets or oral Solution

Lot No: 4

II.2.2)Additional CPV code(s)

33600000

II.2.3)Place of performance

NUTS code: UK
Main site or place of performance:

To a location in England to be notified to the successful bidder(s) following contract.

II.2.4)Description of the procurement:

This procurement exercise may result in one or more contracts for the provision of Azithromycin 250 mg capsules.

The approximate volumes required by the authority are up to 20 million capsules in packs of up to 6 capsules.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 15/06/2020
End: 31/01/2021
This contract is subject to renewal: no

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: yes
Description of options:

The contract has the option to be extended for up to an additional 4 months and the option for the authority to order an additional volume of the goods to be procured by up to 50 % subject to the agreement of the supplier.

II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

Lots may be awarded to more than one supplier depending on volume offered and in accordance with the authority’s requirements as further specified in the procurement documents.

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

III.1.2)Economic and financial standing

Selection criteria as stated in the procurement documents

III.1.3)Technical and professional ability

Selection criteria as stated in the procurement documents
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Open procedure
Accelerated procedure
Justification:

The Covid-19 outbreak has given rise to an urgent need for the supply of lopinavir/ritonavir — tablets or oral solution; hydroxychloroquine – tablets; dexamethasone — oral solution or tablets and azithromycin — capsules, tablets or oral solution because the authority needs to be in a position to treat the population as required. This does not give the Authority sufficient time to comply with the standard open procedure timescales for this procurement. The authority considers this to be a state of urgency which it has duly substantiated. Accordingly, the authority is using the accelerated time limits permitted under the Public Contract Regulations 2015 (Regulation 27(5) for the open procedure) in respect of this procurement.

IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 29/05/2020
Local time: 13:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English

IV.2.6)Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 31/07/2020

IV.2.7)Conditions for opening of tenders

Date: 29/05/2020
Local time: 13:00
Information about authorised persons and opening procedure:

Department of Health and Social Care employee.

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no
VI.2)Information about electronic workflows

VI.3)Additional information:

Any supplier may be disqualified who does not respond to the following in the requisite manner:

1) Submission of expression of interest and procurement specific information

This procurement exercise will be conducted on the eTendering portal at https://dh.bravosolution.co.uk. Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:

1.1) If not already registered, Candidates should register on the eTendering portal at https://dh.bravosolution.co.uk and click the link to register:

— accept the terms and conditions and click continue;

— enter your correct business and user details;

— note the username you chose and click ‘Save’ when complete,

— you will shortly receive an email with your unique password (please keep this secure).

1.2) Once registered, candidates must express interest as follows:

(a) login to the eTendering portal;

(b) select ‘Response to ITT’;

(c) select ‘ITTs Open To All Suppliers’;

(d) access listing related to this procurement contract for the supply of stockpiled medicines and view details;

(e) click on “Express interest” button at the top of the page.

(f) Once you have expressed interest, the ITT will move to ‘My ITTs’, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the ‘Publish’ button.

1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk at +44 800 069 8630 or help@bravosolution.co.uk

2) General supplier information.

To manage and assess supplier information the contracting authority requests candidates provide their company profile in the Governments supplier information database, Supplier Registration, as follows:

2.1) If not already registered, candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk and select ‘Register’ at the top right of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on supplier registration.

2.2) Once registration is complete you are able to create and update your registered company profile. Candidates should ensure all the mandatory fields of their sid4gov profile are completed and up to date for each procurement exercise. D&B data will be supplied automatically by D&B.

2.3) For further help or information concerning supplier registration, please contact the Helpdesk at: support@nqc.com or telephone +44 (0) 845 299 2994.

The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.

VI.4)Procedures for review

VI.4.1)Review body

Official name: The High Court
Town: London
Postal code: WCA 2LL
Country: United Kingdom
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained

VI.5)Date of dispatch of this notice:

13/05/2020